Fewer than 4 out of 10 adults received influenza vaccinations last winter, the lowest rate in 7 seasons; methamphetamine use is rising across the United States, but it is overshadowed by opioids and fatal overdoses; tobacco giant Altria will stop selling e-cigarette “pods” and will pull almost all its flavored products from the market in an attempt to help curb teen vaping.
Fewer than 4 out of 10 adults received influenza vaccinations last winter, the lowest rate in 7 seasons, The Washington Post reported. The CDC said it is a likely reason that the 2017-2018 season was the deadliest in decades. Vaccination coverage among adults was 37.1%, a decrease of 6.2 percentage points from the previous season.
Methamphetamine use is rising across the United States, but it is overshadowed by opioids and fatal overdoses, NPR reported. The drug is stronger and cheaper than it used to be, and is now the product of Mexican drug cartels that are mass-producing high-quality quantities of the drug and pushing it into markets where it was previously unknown. Even in rural communities ravaged by decades of experience with the drug, meth is on the upswing thanks to its relatively low price, availability, and a shortage of treatment options.
Tobacco giant Altria will stop selling e-cigarette “pods” and will pull almost all its flavored products from the market in an attempt to help curb teen vaping. The Hill noted that e-cigarettes make up just a fraction of Altria’s sales, so it has much less to lose than a company like dominant player Juul, which only makes e-cigarettes. Altria, which makes Marlboro and Virginia Slim cigarettes, also said it supports federal legislation to raise the legal smoking age to 21. The company is the first to pull the pods as the FDA is cracking down on e-cigarette manufacturers amid a huge increase in teen vaping.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Homelessness Compounds Hospital Stay Challenges: Study Reveals Prolonged Discharge Struggles
March 28th 2024In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a homeless population, and whether age and/or injury severity had an influence on that relationship—with implications for improving the discharge process for these patients.
Read More
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More